Charles K. Jablecki, MD, University of California San Diego: In the February 2011 issue of Neurology: Clinical Practice, the article by Johnston et al.
1 covered many ethical issues that have arisen in my practice in the evaluation and management of several hundred patients with ALS over the past 30ϩ years. I suggest you consider an alternative phrase to "Physicians cannot abandon patients, even if faced with unacceptable behavior or requests." I recommend replacing it with "Physicians should try to continue to work with their patients, even in the face of behavior or requests that seem unreasonable. The request or behavior should prompt an inquiry with the hope of identifying the basis of the request or behavior with the hope of providing alternative approaches to address the patient needs that underlie the request or behavior." There are situations where a physician should transfer care of a patient with ALS to another physician for further care. In my own practice, if a patient elects to have a tracheostomy and use continuous mechanical ventilation, I have the pulmonologist assume primary care as I do not have the experience to manage the patient's daily needs. I have not "abandoned" the patient. Finally, there are instruments to help estimate the time from the onset of weakness to the development of respiratory insufficiency leading to death.
Most ethicists distinguish forgoing or withdrawing life-sustaining therapies from physicians hastening death (assisted suicide or euthanasia). It is debatable whether a family would regard suicide (whether physician-assisted or not) as less devastating than a planned withdrawal from a ventilator.
Initially addressing the patient's perceptions that ALS could only be a "long-lasting agony," presenting the current interventions and strategies that improve quality of life as well as potentially extend meaningful life, may have prevented the chaos and distress that ensued. Fear of future suffering as well as concerns about burdening family are the most prominent reasons for interest in hastening death. The desire to remain autonomous and in control is also a major motivation. Physician-assisted death is legal in only a few jurisdictions; concerns that it might be viewed as "convenient" may be a motivating factor to those who oppose it.
Dr. Jablecki's thoughts and suggestions are appreciated. The positive reframing of the statement about physicians remaining available to their patients with ALS is welcome. In no way do we feel that appropriate transfer of care, in situations as you describe, represents abandonment. In fact, standard of care would suggest that all patients with ALS be offered care at a specialty multidisciplinary clinic; referral to an ALS clinic does not represent abandonment, but the original physician should not assume the other physician or clinic has taken over until the patient is actually seen or enrolled.
Thank you for drawing our attention to your article about predicting survival. Patients and families often wish to have discussions about prognosis and expectations of timing of interventions. We feel that these are appropriate when tailored to the individual and should occur only after enough information has been gathered over several clinical assessments so as to be meaningful. What we decry is the all-too-familiar statement (or variation thereof) given to patients and families at the time of diagnosis that "average survival is 2 years (or 18 months or 3 years)." In what other neurologic condition is the information so baldly conveyed? The progression of disability and timing of decisions about respiratory and nutritional interventions is highly variable. At the time of diagnosis we honestly do not know what the course will be, so we feel that it is inappropriate to convey these population-based statistics as part of breaking the news. It is the primary axonal degeneration of motor and sensory fibers that can lead to degeneration of muscle fibers. This occurs in critically ill patients, including those with systemic inflammatory response syndrome, sepsis with multiple organ dysfunction syndrome, hyperglycemia, or in those requiring muscle relaxants, corticosteroids, or parenteral nutrition. This may occur in up to 80% of critically ill patients, usually in the form of quadriplegia or quadriparesis, with abolished tendon reflexes and no pathologic changes in the CSF.
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The neurophysiologic study shows primary axonal degeneration of motor and sensory fibers with preservation of conduction velocity, normal distal latency, and potential fall of 
